Business Description
Imugene Ltd
ISIN : AU000000IMU9
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 61.15 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -71 | |||||
3-Year EPS without NRI Growth Rate | -71 | |||||
3-Year FCF Growth Rate | -58.7 | |||||
3-Year Book Growth Rate | 7.2 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 25.1 | |||||
9-Day RSI | 36.65 | |||||
14-Day RSI | 41.46 | |||||
6-1 Month Momentum % | -53.91 | |||||
12-1 Month Momentum % | -14.52 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.86 | |||||
Quick Ratio | 3.86 | |||||
Cash Ratio | 3.23 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -13.8 | |||||
Shareholder Yield % | -12.67 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -89.32 | |||||
ROA % | -77.57 | |||||
ROIC % | -233.12 | |||||
3-Year ROIIC % | -638.72 | |||||
ROC (Joel Greenblatt) % | -1703.56 | |||||
ROCE % | -85 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 3.19 | |||||
Price-to-Tangible-Book | 5.1 | |||||
EV-to-EBIT | -1.94 | |||||
EV-to-Forward-EBIT | -10.28 | |||||
EV-to-EBITDA | -1.94 | |||||
EV-to-Forward-EBITDA | -8.39 | |||||
EV-to-FCF | -2.7 | |||||
Price-to-Net-Current-Asset-Value | 5.1 | |||||
Price-to-Net-Cash | 5.1 | |||||
Earnings Yield (Greenblatt) % | -51.6 | |||||
FCF Yield % | -30.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Imugene Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | |||
EPS (TTM) (A$) | -0.021 | ||
Beta | 2.8 | ||
Volatility % | 171.55 | ||
14-Day RSI | 41.46 | ||
14-Day ATR (A$) | 0.003958 | ||
20-Day SMA (A$) | 0.0552 | ||
12-1 Month Momentum % | -14.52 | ||
52-Week Range (A$) | 0.039 - 0.15 | ||
Shares Outstanding (Mil) | 7,571.11 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Imugene Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Imugene Ltd Stock Events
Event | Date | Price(A$) | ||
---|---|---|---|---|
No Event Data |
Imugene Ltd Frequently Asked Questions
What is Imugene Ltd(ASX:IMU)'s stock price today?
When is next earnings date of Imugene Ltd(ASX:IMU)?
Does Imugene Ltd(ASX:IMU) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |